Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by Lumira.
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| Retatrutide | 21 | 97.74% | Sep 8, 2026 |
| Tirzepatide | 12 | 99.8% | Sep 6, 2026 |
| GHK-Cu | 11 | 99.87% | Aug 4, 2026 |
| Tesamorelin | 8 | 99.68% | Aug 24, 2026 |
| NAD+ | 5 | 98.4% | Jul 21, 2026 |
| BPC-157 | 4 | n/a | Aug 17, 2026 |
| TB-500 | 3 | 98.25% | Aug 4, 2026 |
| HGH | 2 | 99.9% | Sep 3, 2026 |
| TB-500 Thymosin Beta-4 | 1 | 99.5% | Jun 23, 2026 |
| GLOW | 1 | 99.9% | Sep 8, 2026 |
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| Retatrutide | WP-RT20-P00043 | n/a | Lab E | Sep 8, 2026 | verify |
| GLOW | WL-GLOW-P00520 | 99.9% | Lab E | Sep 8, 2026 | verify |
| Tirzepatide | WP-TR30-000041 | n/a | Lab G | Sep 6, 2026 | verify |
| HGH | PPA-WL-T4-P00714 | 99.9% | Lab E | Sep 3, 2026 | verify |
| HGH | WP-H24iu-P00043 | n/a | Lab E | Sep 3, 2026 | verify |
| Retatrutide | WL-RT10-P00521 | 99.7% | Lab G | Aug 30, 2026 | verify |
| Tirzepatide | WL-TR30-P00029 | n/a | Lab K | Aug 26, 2026 | verify |
| Retatrutide | WL-RT30-P00029 | n/a | Lab E | Aug 25, 2026 | verify |
| Retatrutide | WL - R110 000260 | 99.9% | Lab E | Aug 25, 2026 | verify |
| Tesamorelin | WL-TSM20-P00714 | 99.8% | Lab G | Aug 24, 2026 | verify |
| BPC-157 | PPA-WL-BC10-P00704 | n/a | Lab G | Aug 17, 2026 | verify |
| Tirzepatide | PPA-WL-TR20-P00714 | 99.8% | Lab G | Aug 17, 2026 | verify |
| Retatrutide | WL-RT10-P00521 | 99.9% | Lab E | Aug 4, 2026 | verify |
| GHK-Cu | WP- CU100 -P00045 | 99.9% | Lab E | Aug 4, 2026 | verify |
| GHK-Cu | WL-CU-000227 | 99.9% | Lab E | Aug 4, 2026 | verify |
| GHK-Cu | WL-CU100-P000519 | 99.9% | Lab E | Aug 4, 2026 | verify |
| Retatrutide | WL-RT20-P00521 | 99.9% | Lab E | Aug 4, 2026 | verify |
| TB-500 | WL-TB10-P00619 | 96.6% | Lab E | Aug 4, 2026 | verify |
| Tirzepatide | WL-TR30-000296 | 99.9% | Lab E | Aug 4, 2026 | verify |
| GHK-Cu | WL-CU50-000216 | 99.9% | Lab E | Aug 2, 2026 | verify |
| Tirzepatide | WL-TR30-000260 | 99.9% | Lab G | Jul 29, 2026 | verify |
| NAD+ | WP- NJ500 -P00043 | n/a | Lab E | Jul 21, 2026 | verify |
| Retatrutide | WL-RT10-000260 | 99.9% | Lab E | Jul 12, 2026 | verify |
| Retatrutide | WI-RT5-000253 | 99.9% | Lab E | Jul 12, 2026 | verify |
| BPC-157 | n/a | n/a | Lab E | Jul 12, 2026 | verify |
Showing 25 most recent of 68. Search the full database on the CoA page.
Sell or represent Lumira? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/lumira/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/lumira.svg" alt="Lumira: lab tested, 68 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.